Infections that seemed nearly conquered are roaring back
Two of humanity's oldest infectious companions — gonorrhoea and syphilis — have returned to European prominence at levels unseen in decades, unsettling a generation that had largely inherited the assumption these diseases were solved. The resurgence reflects not a single failure but a convergence: shifting patterns of intimacy, the quiet retreat of protective habits, and paradoxically, the success of expanded testing that is now illuminating what was always partially hidden. Europe stands at a familiar crossroads, where the tools to respond exist but the will and coordination to deploy them remain the open question.
- Gonorrhoea and syphilis have hit record highs across Europe, reversing decades of progress and alarming epidemiologists from London to Rome.
- Dating apps, declining condom use among younger adults, and reduced social stigma around casual sex have created wider transmission networks than public health systems anticipated.
- Expanded testing is catching infections that would have gone undetected a decade ago — a sign of progress, but one that also reveals the true scale of a problem long underestimated.
- Gonorrhoea is showing early signs of antibiotic resistance, raising the spectre of infections that standard treatments can no longer reliably cure.
- Sexual health clinics are reporting longer wait times, and public awareness campaigns are being urgently revived to meet a demand that outpaced preparation.
- Whether this becomes a chronic crisis or a turning point depends on how quickly European health systems can reach people where they are — on apps, in feeds, and in honest conversations about risk.
Across Europe, gonorrhoea and syphilis have climbed to levels not seen in decades, alarming public health officials and forcing a reckoning with assumptions that these infections had been effectively tamed. Antibiotics made them manageable for much of the modern era, and awareness campaigns in the 1990s and 2000s pushed case numbers down far enough that the diseases faded from public concern — filed away, prematurely, as solved problems.
The resurgence is being driven by two converging forces. Shifts in sexual behaviour — including the rise of dating apps, declining condom use in some populations, and reduced stigma around casual contact — have created more opportunity for transmission. At the same time, expanded access to testing through clinics and home kits is revealing infections that previously went uncounted. The headline numbers reflect both a genuine increase in transmission and a more complete picture of what was always occurring beneath the surface.
The stakes are not merely statistical. Untreated syphilis can cause neurological and cardiovascular damage, and poses serious risks during pregnancy. Gonorrhoea can lead to infertility and chronic pain. Beyond the medical, those diagnosed face emotional weight, partner disclosure, and the logistics of contact tracing. Adding urgency is the question of antibiotic resistance — gonorrhoea in particular is showing troubling signs that standard treatments may not always hold.
European health systems are now under pressure to respond with speed and reach. Prevention messaging must find people on the platforms where they actually form connections. Testing and treatment access must keep pace with rising demand. And the deeper work — building genuine sexual health literacy, normalising conversations about risk and protection — cannot be deferred. The data is unambiguous. What comes next depends on the choices made in the months ahead.
Across Europe, two infections that seemed nearly conquered are roaring back. Gonorrhoea and syphilis have climbed to levels not seen in decades, according to recent data that has alarmed public health officials from London to Berlin to Rome. The numbers are stark enough that epidemiologists are now asking hard questions about what has changed—and what needs to change in response.
These are not new diseases. Syphilis has haunted human populations since the 16th century. Gonorrhoea has been a fixture of sexual health for just as long. For much of the modern era, antibiotics made them manageable, almost routine to treat. A course of pills, a follow-up test, and the infection cleared. Public health campaigns in the 1990s and 2000s pushed awareness and prevention. Case numbers fell. The diseases receded from the public conversation, filed away as solved problems.
That assumption has proven premature. The resurgence appears driven by two converging forces. First, patterns of sexual behavior have shifted in ways that create more opportunity for transmission. Dating apps have changed how people meet and form connections. Condom use, particularly among younger adults, has declined in some populations. The social stigma around casual sexual contact has loosened, which is not inherently problematic—but it does mean more partners, more encounters, and more exposure risk for those who are not consistently protected.
Second, testing has expanded. More people are getting screened for STIs than ever before. Some of this reflects better access to sexual health clinics and home testing kits. Some reflects a cultural shift toward routine screening as part of regular health maintenance. The result is that infections that might have gone undetected a decade ago are now being caught and counted. This is partly good news—you cannot treat what you do not know you have—but it also means the headline numbers reflect both a genuine increase in transmission and a more complete picture of what was always happening.
Public health systems across Europe are now grappling with the practical fallout. Treatment remains available and effective, but only if people seek it. Awareness campaigns are being revived. Sexual health clinics report longer wait times. There is also the question of antibiotic resistance. Gonorrhoea in particular has shown troubling signs of developing resistance to standard treatments, which means some cases are becoming harder to cure and raising the specter of untreatable infections down the line.
The human dimension is significant. Untreated syphilis can cause serious complications—neurological damage, cardiovascular disease, congenital infection in pregnant women. Gonorrhoea can lead to infertility and chronic pelvic pain. These are not merely statistical concerns. They are conditions that reshape lives. Young people discovering they have an STI face not just medical treatment but emotional weight, questions about disclosure to partners, and the practical logistics of contact tracing and notification.
What happens next depends partly on how European health systems respond. Prevention messaging needs to reach people where they actually are—on dating apps, in social media feeds, in conversations among peers. Access to testing and treatment must keep pace with demand. Condom availability and education about consistent protection remain foundational. And there is the longer conversation about sexual health literacy, about teaching people not just how to avoid infection but how to have conversations with partners about risk and protection.
For now, the trend is upward. The data is clear. Whether these infections become a chronic public health crisis or a moment that prompted meaningful change depends on what Europe does in the months ahead.
Citas Notables
Public health officials are concerned about the resurgence of these previously controlled infections— European health authorities
La Conversación del Hearth Otra perspectiva de la historia
Why are these diseases coming back now, after we thought we had them under control?
We never really had them under control—we just had fewer people testing positive. The antibiotics worked, so we stopped paying attention. But the conditions for transmission never went away. Now we're seeing what was always there, plus some genuine increase in risk behavior.
What changed in sexual behavior?
Dating apps made it easier to meet new partners quickly. Condom use dropped, especially among younger people. There's less stigma around casual sex, which is fine in itself, but it means more exposure for people who aren't consistently protected.
So testing is actually revealing a hidden problem?
Partly. Better testing means we're catching infections we would have missed. But there's also a real increase in transmission. Both things are true at once.
What's the danger if these keep spreading?
Untreated syphilis causes serious damage—brain, heart, birth defects. Gonorrhoea can cause infertility. And gonorrhoea is developing antibiotic resistance, which means some cases may become impossible to treat.
What would actually reverse this trend?
Consistent condom use, accessible testing and treatment, and honest conversations about risk. But that requires sustained public health effort, not just alarm. People need to know this is treatable, not shameful.